← Back to Search
Histopathology Of Parasellar Neoplasms
E. Manojlović-Gačić, Elham Rostami, N. Karavitaki, O. Casar-Borota
Published 2020 · Medicine
Download PDFAnalyze on Scholarcy
The anatomical and histological complexity of the parasellar region as well as the presence of embryonic remnants determine the huge diversity of parasellar neoplasms. Some of them are only located in the parasellar region, whereas others can occur elsewhere, within or outside the central nervous system. Their spectrum ranges from histologically benign and low-grade malignant to high-grade malignant tumours. Although rare, metastases can pose differential diagnostic dilemmas. The severity of the clinical picture, the challenges of surgery and the risk of adverse sequelae related to surgery or radiotherapy make parasellar tumours interesting entities for the clinicians irrespective of their histological malignancy grade. Due to the different cell origins of parasellar tumours, the World Health Organization classification system does not categorise them as a distinct group. Detailed criteria for classification and malignancy grading are presented in the classification systems covering central nervous system tumours, haematological malignancies and tumours of the soft tissue and bone. In the last few years, molecular genetic features have been integrated into the diagnosis of several types of the parasellar tumours enhancing diagnostic accuracy and providing information of the value for targeting therapies. In this review, we will present histopathological and molecular genetic features, updated classification criteria and recent advances in the diagnostics and rationale for novel pharmacological therapies of selected types of parasellar neoplasms.
This paper references
Intracranial dysembryogenetic tumors: pathogenesis and their order of malignancy
K. Sano (2001)
22 Microsurgical and Endoscopic Anatomy of the Parasellar Region
A. Stamm (2011)
Über Hypophysengangsgeschwül - ste und Hirncholesteatome
J Erdheim (1904)
Endoscopic endonasal surgery for nonadenomatous sellar/parasellar lesions.
G. Barkhoudarian (2014)
Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations.
S. Sekine (2002)
Stem cell research points the way to the cell of origin for intracranial germ cell tumours
Chris Tan (2013)
Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans
C. Gaston-Massuet (2011)
Sella Turcica Atypical Teratoid/Rhabdoid Tumor Complicated with Lung Metastasis in an Adult Female
C. Moretti (2013)
Behari S. Nonsecretory paraganglioma in cavernous sinus masquerading as meningioma
Notochordal Tumors: An Update on Molecular Pathology with Therapeutic Implications.
Takehiko Yamaguchi (2017)
Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast‐rich mimics
N. Presneau (2015)
Sellar and parasellar lesions – Clinical outcome in 61 children
C. Unsinn (2014)
Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy
K. Ichimura (2016)
Atypical teratoid/rhabdoid tumour in sella turcica in an adult
K. Arita (2008)
Dual BRAF/MEK therapy in BRAF V600E-mutated primary brain tumors: a case series showing dramatic clinical and radiographic responses and a reduction in cutaneous toxicity.
Aaron Bernstein (2019)
Loss of SMARCB1/INI1 expression in poorly differentiated chordomas
B. Mobley (2010)
Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report
M. Rao (2019)
Wholeexome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas
L Fishbein (2015)
Hemangiopericytoma of the sella mimicking pituitary adenoma: case report and review of the literature.
J. Juco (2007)
Pituitary Metastases: A Nationwide Study on Current Characteristics With Special Reference to Breast Cancer.
Fredrika Schill (2019)
Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma
C. Andoniadou (2012)
World Health Organization Classification of Tumours of the Central Nervous System. Revised
DN Louis (2016)
Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway
N. Presneau (2009)
Mutations in SDHC cause autosomal dominant paraganglioma, type 3
S. Niemann (2000)
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.
B. Baysal (2000)
BRAF V 600 E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB 1 - mutated adaman - tinomatous craniopharyngioma
SJ Larkin (2014)
Whole exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors
J. Chmielecki (2013)
Fully endoscopic combined transsphenoidal and supraorbital keyhole approach for parasellar lesions.
Y. Nagata (2018)
Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma
S. Coy (2018)
Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functionalbased study
N Presneau (2011)
Why human extragonadal germ cell tumours occur in the midline of the body: old concepts, new perspectives.
J. W. Oosterhuis (2007)
Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas
P. Brastianos (2014)
Coexistence of adamantinomatous and squamous‐papillary type craniopharyngioma: Case report and discussion of etiology and pathology
Tomu Okada (2012)
Variable methylation of the imprinted gene, SNRPN, supports a relationship between intracranial germ cell tumours and neural stem cells
Shih-Han Lee (2010)
H3F3 mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach
T. Kervarrec (2017)
Exon 3 mutations of CTNNB1 drive tumorigenesis: a review
C. Gao (2018)
Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor
S. Aylwin (2015)
Distinct clinicopathological features of NAB2-STAT6 fusion gene variants in solitary fibrous tumor with emphasis on the acquisition of highly malignant potential.
K. Akaike (2015)
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
D. Capper (2011)
Encyclopedia of endocrine diseases
L. Martini (2004)
A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle
Benjamin Goode (2018)
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
M. F. Amary (2011)
VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation
J. Sperveslage (2013)
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
S. Swerdlow (2017)
Non secretory Paraganglioma in cavernous sinus masquerading as meningioma.
S. Singh (2019)
Gene Fusion in Meningeal Hemangiopericytoma and Solitary Fibrous Tumor
Solitary Fibrous Tumor of the Central Nervous System: A 15-year Literature Survey of 220 Cases (August 1996–July 2011)
M. Bisceglia (2011)
Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features.
Sarah Barthelmeß (2014)
The impact of histopathology and NAB2–STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytoma
K. Fritchie (2018)
Malignancy in giant cell tumor of bone
F. Bertoni (2003)
Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma.
S. Fjalldal (2013)
VE 1 Antibody Immunoreactivity in Normal Anterior Pituitary and Adrenal Cortex Without Detectable BRAF V 600 E Mutations
Daniel A. Mordes (2014)
Meningeal heman - giopericytoma and solitary fibrous tumors carry the NAB 2 - STAT 6 fusion and can be diagnosed by nuclear expression of STAT 6 protein
L Schweizer (2013)
Solitary fibrous tumor of the central nervous system: a 15-year literature survey of 220 cases
M Bisceglia (1996)
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
F. V. van Nederveen (2009)
The driver landscape of sporadic chordoma
P. Tarpey (2017)
Systematic review of clinical, radiologic, and histologic features of benign notochordal cell tumors: implications for patient management. World Neurosurg
Systematic Review of Clinical, Radiologic, and Histologic Features of Benign Notochordal Cell Tumors: Implications for Patient Management.
I. Usher (2019)
Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.
D. Astuti (2001)
Identifica - tion of recurrent NAB 2 - STAT 6 gene fusions in solitary fibrous tumor by integrative sequenc
p53 mutations may be involved in malignant transformation of giant cell tumor of bone through interaction with GPX1
Taketo Okubo (2013)
Genetic and immune profiling for potential therapeutic targets in adult human craniopharyngioma
Cynthia Kassab (2019)
Gamma Knife radiosurgery for sellar and parasellar meningiomas: a multicenter study.
J. Sheehan (2014)
Transnasal Endoscopic Skull Base and Brain Surgery: Tips and Pearls
A. Stamm (2011)
Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma
S. Job (2018)
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.
P. Brastianos (2016)
Pheochromocytoma and paraganglioma.
K. Pacak (2015)
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
G. Schindler (2011)
Integrated Clinical, Histopathological, and Molecular Data Analysis of 190 Central Nervous System Germ Cell Tumors from the iGCT Consortium.
H. Takami (2019)
SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas.
E. Korpershoek (2011)
Recurrence of giant cell tumour of bone: role of p53, cyclin D1, β-catenin and Ki67
N. Lujić (2016)
Invasive Giant Cell Tumor of the Lateral Skull Base: A Systematic Review, Meta-Analysis, and Case Illustration.
Jacob L. Freeman (2016)
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
Dan R. Robinson (2013)
SDH5, a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma
Huai-Xiang Hao (2009)
Rosai J. World Health Organization classification of tumours of endocrine organs
RV Lloyd (2017)
What’s New in Thyroid Tumor Classification, the 2017 World Health Organization Classification of Tumours of Endocrine Organs
G. Tallini (2019)
Benign Notochordal Cell Tumors: A Comparative Histological Study of Benign Notochordal Cell Tumors, Classic Chordomas, and Notochordal Vestiges of Fetal Intervertebral Discs
Takehiko Yamaguchi (2004)
The Medical Therapy of Craniopharyngiomas: The Way Ahead.
K. Alexandraki (2019)
Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations
T. Juratli (2019)
Chordoma: update on disease, epidemiology, biology and medical therapies
A. Frezza (2019)
Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis
M. Hasselblatt (2016)
Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas.
J. Gaal (2010)
SDHA is a tumor suppressor gene causing paraganglioma.
N. Burnichon (2010)
Primary Lymphoma of the Skull Base in the Chinese: Clinical, Radiological, Pathological, and Therapeutic Experience in a Series of 8 Patients.
X. Meng (2019)
NAB2-STAT6 Gene Fusion in Meningeal Hemangiopericytoma and Solitary Fibrous Tumor
K. Fritchie (2016)
Incidence of intracranial germ cell tumors by race in the United States, 1992–2010
J. Poynter (2014)
Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas.
D. Jones (2008)
Re - current papillary craniopharyngioma with BRAFV 600 E mutation treated with neoadju - vant - targeted therapy
Molecular evaluation of a sporadic paraganglioma with concurrent IDH1 and ATRX mutations
J. Zhang (2018)
Unusual and Rare Locations for Craniopharyngiomas: Clinical Significance and Review of the Literature.
B. Gabel (2017)
WHO classification of tumours of soft tissue and bone
C. D. Fletcher (2013)
Peculiar pathological, radiological and clinical features of skull‐base de‐differentiated chordomas. Results from a referral centre case–series and literature review
S. Asioli (2019)
Primary Sellar Paraganglioma: Case Report with Literature Review and Immunohistochemistry Resource.
Seán B. Lyne (2019)
Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases
M. Miettinen (2015)
Atypical teratoid/rhabdoid tumor of the brain
A. Parwani (2005)
Unusual causes of sellar/parasellar masses in a large transsphenoidal surgical series.
P. Freda (1996)
Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas Assessment of BRAF V 600 E mutation status by immunohistochemistry with a mutation - specific monoclonal antibody
Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone
S. Behjati (2013)
The sellar region.
A. Rhoton (2002)
Malignant Giant Cell Tumor of the Skull Base Originating From Clivus and Sphenoid Bone
F. Zorlu (2005)
T (brachyury) gene duplication confers major susceptibility to familial chordoma
X. Yang (2009)
Type, Frequency, and Spatial Distribution of Immune Cell Infiltrates in CNS Germinomas: Evidence for Inflammatory and Immunosuppressive Mechanisms
Pia Zapka (2018)
Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma
Arjen H. G. Cleven (2015)
Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas
S. Vujovic (2006)
The enigma of bifocal germ cell tumors in the suprasellar and pineal regions: synchronous lesions or metastasis?
J. H. Phi (2013)